Answers are grounded in this paper and cite their sources.
Amide bonds are prevalent in pharmaceuticals and bioactive compounds, yet traditional chemical synthesis relies on harsh conditions and generates stoichiometric waste. Biocatalysis offers a promising green approach. An acetyl-CoA synthetase from Methanocella arvoryzae (MethACS) was previously characterized for phenylalanine butylamide (FBA) production with poor performance. This study combined enzyme engineering and process intensification to enhance aqueous-phase FBA production. Guided by synergistic computational prediction and few-shot active learning, potential mutation sites were identified. The optimal mutant M450I/I546F was further obtained through greedy iterative combination, with 2.42-fold increased activity and prolonged half-life from 1.5 to 6.5 h at 60 °C. Then, the polyphosphate kinase 2-III (PPK2-III) and inorganic pyrophosphatase (PPI) were mined to construct a three-enzyme cascade for ATP regeneration and pyrophosphate (PPi) hydrolysis, resulting in a 5.52-fold increase in FBA concentration. Furthermore, the CipA-mediated self-assembly multienzyme cascade achieved the cyclic regeneration of ATP and a FBA yield of 2.34 g/L. Benefiting from system-level coordination, complete conversion of butyric acid was achieved with only a 2-fold excess amine substrate (previously required ≥4-fold excess), yielding an FBA titer of 2.34 g/L. This work provides a platform for green synthesis of high-value amides.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: